InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the full record of transactions filed by François LACOSTE, Directeur Exécutif Recherche & Développement. Director active across 1 company, notably BIOMERIEUX. Aggregated, 5 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €2k. Activity tracked since 26 February 2022. The latest transaction was disclosed on 1 September 2023 (Attribution gratuite d'actions). Regulator: AMF. The full history is openly available.
Companies and markets linked to François LACOSTE
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,203 shares0Actions gratuitesHors plateforme de négociationISIN FR00132802862026DD1136012
Canonical exit: 29 Nov 2026 (T+90)
3,250 shares0ActionHors plateforme de négociationISIN FR00132802862023DD926498
25.87 shares@ €77.31100.0% of flowActionHors plateforme de négociationISIN FR00132802862023DD920724
Canonical exit: 21 Sept 2023 (T+90)
5,375 shares0ActionAcquisitions d'actions gratuiteISIN FR00132802862022DD824955
Canonical exit: 27 May 2022 (T+90)
5,375 shares0ActionHors plateforme de négociationISIN FR00132802862022DD825460
Canonical exit: 27 May 2022 (T+90)
5 of 5 declarations
About François LACOSTE
François Lacoste is the Executive Vice-President of Research & Development at bioMérieux. He leads the company's research and innovation efforts, which specializes in in vitro diagnostics. His role is essential for the development of new diagnostic solutions and for maintaining bioMérieux's leading position in the market.
